Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan W Dellinger

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Biological Chemistry|October 24, 2018
Oxidative stress and antioxidants in the pathophysiology of malignant melanomaElena Obrador, Feng Liu-Smith, Ryan W Dellinger, et al.
NPJ Aging and Mechanisms of Disease|November 30, 2017
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD<sup>+</sup> levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled studyRyan W Dellinger, Santiago Roel Santos, Mark Morris, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2009
Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 geneKristine C Olson, Ryan W Dellinger, Qing Zhong, et al.
International Journal of Toxicology|July 28, 2020
Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery ArmAnca G Marinescu, Jayson Chen, Holly E Holmes, et al.
Hepatology (Baltimore, Md.)|November 4, 2016
Nicotinamide adenine dinucleotide biosynthesis promotes liver regenerationSarmistha Mukherjee, Karthikeyani Chellappa, Andrea Moffitt, et al.
Frontiers in Aging|May 29, 2026
Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trialHolly E Holmes, Kamal Srivastava, Jennifer M Scalici, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Pterostilbene in Cancer TherapyElena Obrador, Rosario Salvador-Palmer, Ali Jihad-Jebbar, et al.
The Journal of Cell Biology|May 1, 2002
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2Lisa A Porter, Ryan W Dellinger, John A Tynan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 19, 2024
Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS miceRafael López-Blanch, Rosario Salvador-Palmer, María Oriol-Caballo, et al.
Hepatology (Baltimore, Md.)|September 9, 2022
Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trialRyan W Dellinger, Holly E Holmes, Tina Hu-Seliger, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Biological Chemistry|October 24, 2018
Oxidative stress and antioxidants in the pathophysiology of malignant melanomaElena Obrador, Feng Liu-Smith, Ryan W Dellinger, et al.
NPJ Aging and Mechanisms of Disease|November 30, 2017
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD<sup>+</sup> levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled studyRyan W Dellinger, Santiago Roel Santos, Mark Morris, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2009
Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 geneKristine C Olson, Ryan W Dellinger, Qing Zhong, et al.
International Journal of Toxicology|July 28, 2020
Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery ArmAnca G Marinescu, Jayson Chen, Holly E Holmes, et al.
Hepatology (Baltimore, Md.)|November 4, 2016
Nicotinamide adenine dinucleotide biosynthesis promotes liver regenerationSarmistha Mukherjee, Karthikeyani Chellappa, Andrea Moffitt, et al.
Frontiers in Aging|May 29, 2026
Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trialHolly E Holmes, Kamal Srivastava, Jennifer M Scalici, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Pterostilbene in Cancer TherapyElena Obrador, Rosario Salvador-Palmer, Ali Jihad-Jebbar, et al.
The Journal of Cell Biology|May 1, 2002
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2Lisa A Porter, Ryan W Dellinger, John A Tynan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 19, 2024
Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS miceRafael López-Blanch, Rosario Salvador-Palmer, María Oriol-Caballo, et al.
Hepatology (Baltimore, Md.)|September 9, 2022
Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trialRyan W Dellinger, Holly E Holmes, Tina Hu-Seliger, et al.
Pageof 5